SECreport

Form 4 TherapeuticsMD, Inc. For: May 13 Filed by: Collins Cooper C.

TherapeuticsMD, Inc.  (TXMD) 
NASDAQ:AMEX Investor Relations: ir.therapeuticsmd.com